CA.ME.LI.A. An epidemiological study on the prevalence of CArdiovascular, MEtabolic, LIver and Autoimmune diseases in Northern Italy.
暂无分享,去创建一个
D. Baldassarre | F. Folli | R. Paroni | A. Russo | P. Battezzati | M. Zuin | M. Dei Cas | M. Bignotto | Elena Bianco | P. Zermiani | M. G. Gangale | V. Zadro | M. Maregatti | A. Piagnani | M. Gangale | E. Bianco | Alessandra Piagnani
[1] R. DeFronzo,et al. Pioglitazone corrects dysregulation of skeletal muscle mitochondrial proteins involved in ATP synthesis in type 2 diabetes. , 2020, Metabolism: clinical and experimental.
[2] V. Wong,et al. A new definition for metabolic associated fatty liver disease: an international expert consensus statement. , 2020, Journal of hepatology.
[3] D. Baldassarre,et al. Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population. , 2019, International journal of cardiology.
[4] M. Iriti,et al. Bioactive phytochemicals of tree nuts. Determination of the melatonin and sphingolipid content in almonds and pistachios , 2019, Journal of Food Composition and Analysis.
[5] F. Folli,et al. Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). , 2018, Pharmacological research.
[6] O. Barbarash,et al. Localization of fat depots and cardiovascular risk , 2018, Lipids in Health and Disease.
[7] A. Konradi,et al. Epidemiology of cardiovascular risk factors in two population-based studies. , 2018, Atherosclerosis. Supplements.
[8] P. Francesconi,et al. FP354PREVALENCE OF CHRONIC KIDNEY DISEASE IN ITALY: THE ROLE OF DEMOGRAPHIC SHIFT TOWARDS OLDER AGE GROUPS , 2018 .
[9] A. Lonardo,et al. Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence? , 2018, Journal of hepatology.
[10] F. Valente,et al. Hypertriglyceridemia, an Underestimated Cardiovascular Risk Factor: An Epidemiological Study of the Rome Area , 2017, High Blood Pressure & Cardiovascular Prevention.
[11] G. Marchesini,et al. AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. , 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[12] C. Caserta,et al. Seroepidemiology of HEV and HAV in two populations with different socio-economic levels and hygienic/sanitary conditions , 2017, European Journal of Clinical Microbiology & Infectious Diseases.
[13] Meric Erikci Ertunc,et al. Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment , 2016, Journal of Lipid Research.
[14] Amjad M Ahmed,et al. Cardiovascular risk factors burden in Saudi Arabia: The Africa Middle East Cardiovascular Epidemiological (ACE) study , 2016, Journal of the Saudi Heart Association.
[15] E. Benjamin,et al. The Future of Cardiovascular Epidemiology , 2016, Circulation.
[16] Luigi Palmieri,et al. Cardiovascular health in Italy. Ten-year surveillance of cardiovascular diseases and risk factors: Osservatorio Epidemiologico Cardiovascolare/Health Examination Survey 1998–2012 , 2015, European journal of preventive cardiology.
[17] G. Sesti,et al. Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease , 2014, BMJ Open Diabetes Research and Care.
[18] H. Sillesen. Carotid intima-media thickness and/or carotid plaque: what is relevant? , 2014, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[19] R. DeFronzo,et al. Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3–TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study , 2013, Diabetologia.
[20] M. Federici,et al. The role of ADAM17 in metabolic inflammation. , 2013, Atherosclerosis.
[21] Enzo Grossi,et al. Measurements of carotid intima-media thickness and of interadventitia common carotid diameter improve prediction of cardiovascular events: results of the IMPROVE (Carotid Intima Media Thickness [IMT] and IMT-Progression as Predictors of Vascular Events in a High Risk European Population) study. , 2012, Journal of the American College of Cardiology.
[22] L. Piemonti,et al. Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up , 2012, Acta Diabetologica.
[23] S. Menini,et al. Overexpression of Tissue Inhibitor of Metalloproteinase 3 in Macrophages Reduces Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[24] A. Rubinstein,et al. Cardiovascular disease research in Latin America: a comparative bibliometric analysis. , 2011, World journal of cardiology.
[25] Paolo Crosignani,et al. Fatty liver index and mortality: The cremona study in the 15th year of follow‐up , 2011, Hepatology.
[26] E. Trabetti,et al. Variants of GCKR Affect Both β-Cell and Kidney Function in Patients With Newly Diagnosed Type 2 Diabetes , 2011, Diabetes Care.
[27] M. Reilly,et al. Gender differences in the association of C‐reactive protein with coronary artery calcium in Type‐2 diabetes , 2011, Clinical endocrinology.
[28] L. Luzi,et al. Prevalence, Metabolic Features, and Prognosis of Metabolically Healthy Obese Italian Individuals , 2010, Diabetes Care.
[29] Eric Boerwinkle,et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. , 2010, Journal of the American College of Cardiology.
[30] A. Gasbarrini,et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[31] R. DeFronzo,et al. Impaired regulation of the TNF-α converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans , 2009, Diabetologia.
[32] Makoto Watanabe,et al. Cardiovascular Disease and Risk Factors in Asia: A Selected Review , 2008, Circulation.
[33] Poonam Mishra,et al. Abdominal Ultrasound for Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) , 2007, The American Journal of Gastroenterology.
[34] M. Criqui,et al. Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. , 2006, American heart journal.
[35] D. Accili,et al. Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. , 2005, The Journal of clinical investigation.
[36] A. Naska,et al. Mediterranean diet in relation to body mass index and waist-to-hip ratio: the Greek European Prospective Investigation into Cancer and Nutrition Study. , 2005, The American journal of clinical nutrition.
[37] A. Khera,et al. Race and gender differences in C-reactive protein levels. , 2005, Journal of the American College of Cardiology.
[38] S. Haffner,et al. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. , 2005, Diabetes care.
[39] J. Tuomilehto,et al. Trends in obesity and energy supply in the WHO MONICA Project , 2004, International Journal of Obesity.
[40] G. Berenson. Childhood risk factors predict adult risk associated with subclinical cardiovascular disease. The Bogalusa Heart Study. , 2002, The American journal of cardiology.
[41] G. Reaven,et al. Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. , 1999, Metabolism: clinical and experimental.
[42] A. Nissinen,et al. Comparison of multivariate predictive power of major risk factors for coronary heart diseases in different countries: results from eight nations of the Seven Countries Study, 25-year follow-up , 1996 .
[43] G. Gallus,et al. Epidemiology of known diabetes in Lombardy, north Italy , 1995, Acta Diabetologica.
[44] D Kromhout,et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. , 1995, JAMA.
[45] E. Bonora,et al. The Verona diabetes study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality , 1995, Diabetologia.
[46] E. Bonora,et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. , 1989, The New England journal of medicine.
[47] V. Lorenzoni,et al. The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: a multicenter study in Italy. , 2015, Clinica chimica acta; international journal of clinical chemistry.
[48] S. Grundy,et al. National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .
[49] L. Freedman. Tables of the number of patients required in clinical trials using the logrank test. , 1982, Statistics in medicine.